<?xml version="1.0" encoding="utf-8"?>
<rdf:Description rdf:about="http://archives.rcpe.ac.uk/CalmView/record/catalog/RCP/COL/9/818" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Consultation response to the Medicines and Healthcare Products Regulatory Agency (MHRA) on 'Consultation Letter MLX 311 - Introduction of new offences relating to information submitted in support of an application for the grant, renewal or variation of a marketing authorisation, or in specified circumstances during the currency of an authorisation, information supplied in relation to 'specials', information supplied during the currency of a manufacturer's or wholesale dealer's licence, and additional record-keeping requirements in respect of manufacturers of biological medicinal products for human use'</dc:title>
  <dc:description></dc:description>
  <dc:date>2005</dc:date>
</rdf:Description>